Price$5.81+0.21 (+3.75%)
01:30 PM07:45 PM
News · 26 weeks41-45%
2026-01-182026-07-12
Mix2390d
- Insider13(57%)
- SEC Filings6(26%)
- Earnings2(9%)
- Leadership1(4%)
- Analyst1(4%)
Latest news
25 items- PREvolent To Release Second Quarter 2026 Financial Results on Thursday, August 6, 2026WASHINGTON, July 8, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its second quarter 2026 financial results on Thursday, August 6, 2026, before market open, with a conference call to follow at 8 a.m. ET.Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.An audio p
- INSIDERChief Executive Officer Blackley Seth was granted 446,102 shares and covered exercise/tax liability with 10,297 shares, increasing direct ownership by 52% to 1,272,767 units (SEC Form 4) (tax liability)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERGeneral Counsel Weinberg Jonathan was granted 43,055 shares and covered exercise/tax liability with 2,650 shares, increasing direct ownership by 17% to 284,917 units (SEC Form 4) to satisfy tax liability4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERPRESIDENT Mccarthy Daniel Joseph was granted 302,585 shares and covered exercise/tax liability with 4,582 shares, increasing direct ownership by 70% to 721,025 units (SEC Form 4) to cover withholding tax4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERChief Accounting Officer Shams Aammaad was granted 28,790 shares, increasing direct ownership by 43% to 95,637 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- ANALYSTEvolent Health downgraded by Truist with a new price targetTruist downgraded Evolent Health from Buy to Hold and set a new price target of $7.00
- SECSEC Form S-8 filed by Evolent Health IncS-8 - Evolent Health, Inc. (0001628908) (Filer)
- INSIDERDirector Ajayi Toyin was granted 41,096 shares, increasing direct ownership by 121% to 75,170 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Glass Russell Monroe was granted 41,096 shares, increasing direct ownership by 113% to 77,347 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Grua Peter J was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Guertin Shawn M was granted 41,096 shares, increasing direct ownership by 187% to 63,075 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Jelinek Richard M was granted 41,096 shares, increasing direct ownership by 113% to 77,533 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Keck Kim was granted 41,096 shares, increasing direct ownership by 67% to 102,597 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Smith Jill D. was granted 41,096 shares, increasing direct ownership by 178% to 64,233 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Springstubb Brendan B was granted 41,096 shares, increasing direct ownership by 70% to 99,917 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- INSIDERDirector Barbarosh Craig A. was granted 41,096 shares, increasing direct ownership by 76% to 95,031 units (SEC Form 4)4 - Evolent Health, Inc. (0001628908) (Issuer)
- SECEvolent Health Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Evolent Health, Inc. (0001628908) (Filer)
- PRQuest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product OfficerAccomplished product leader to drive innovation, platform strategy, and AI-powered solutions for health plan clientsOVERLAND PARK, Kan., May 12, 2026 /PRNewswire/ -- Quest Analytics® today announced the appointment of Chris Lance as Chief Product Officer (CPO). In this role, Lance will lead vision, strategy, and execution across the company's full product portfolio, driving innovation that helps health plans build, manage, model, and optimize high-performing provider networks. Lance brings more than 20 years of experience leading product and technology organizations, with a prov
- SECSEC Form 10-Q filed by Evolent Health Inc10-Q - Evolent Health, Inc. (0001628908) (Filer)
- SECEvolent Health Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Evolent Health, Inc. (0001628908) (Filer)
- PREvolent Announces First Quarter 2026 ResultsWASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH) ("Evolent" or the "Company"), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months ended March 31, 2026.Seth Blackley, Co-Founder and Chief Executive Officer of Evolent stated, "I am happy with the strong start to the year. We are on track with our plan and have had successful, on-time oncology launches at both Highmark and Aetna. As we look into 2027 and beyond, we remain focused on both extending our market leadership in oncology and addressing the big opp
- SECSEC Form DEF 14A filed by Evolent Health IncDEF 14A - Evolent Health, Inc. (0001628908) (Filer)
- SECSEC Form DEFA14A filed by Evolent Health IncDEFA14A - Evolent Health, Inc. (0001628908) (Filer)
- PREvolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE:EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its first quarter 2026 financial results on Thursday, May 7, 2026, before market open, with a conference call to follow at 8 a.m. ET.Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, https://ir.evolent.com.Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call.An audio play
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Evolent Health IncSCHEDULE 13G/A - Evolent Health, Inc. (0001628908) (Subject)
EVH FAQ
7 questionsWhat does Evolent Health Inc do?
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates through two segments, Services and True Health. The Services segment provides value-based care services that include Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows and engages patients; population health performance that delivers patient-centric cost effective care; and delivery network alignments. This segment also offers specialty care management solutions that support a range of...Where does EVH stock trade?
Evolent Health Inc (EVH) is listed on NYSE.What sector and industry is EVH in?
Evolent Health Inc operates in the Consumer Discretionary sector, Other Consumer Services industry.When did Evolent Health Inc go public?
Evolent Health Inc (EVH) completed its IPO in 2015.What are analysts saying about EVH?
Evolent Health Inc has had 8 recent analyst actions on file. The most recent action was from Truist: Hold with a $700.00 price target on 2026-06-30. Recent price targets range from $700.00 to $3500.00.What companies are similar to EVH?
Notable peers in the same industry include BAM (Brookfield Asset Management Inc), SE (Sea Limited), RTO (Rentokil Initial plc), SCI (Service Corporation International), IT (Gartner Inc.). Compare EVH side-by-side with any of them on Quantisnow.How can I track EVH on Quantisnow?
Quantisnow aggregates Evolent Health Inc's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow EVH to receive live email and push alerts on every new disclosure.